Orum Therapeutics, Inc. (KOSDAQ:475830)
45,500
 +3,850 (9.24%)
  Oct 30, 2025, 3:30 PM KST
9.24% (1Y)
| Market Cap | 962.71B | 
| Revenue (ttm) | 20.88B | 
| Net Income (ttm) | -8.83B | 
| Shares Out | 21.16M | 
| EPS (ttm) | -675.12 | 
| PE Ratio | n/a | 
| Forward PE | n/a | 
| Dividend | n/a | 
| Ex-Dividend Date | n/a | 
| Volume | 451,958 | 
| Average Volume | 206,773 | 
| Open | 41,200 | 
| Previous Close | 41,650 | 
| Day's Range | 40,700 - 45,950 | 
| 52-Week Range | 15,950 - 45,950 | 
| Beta | n/a | 
| RSI | 72.40 | 
| Earnings Date | Nov 14, 2025 |